CLAIRE STABLEIN: Open Payments
NPI 1225875966 · KENOSHA, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,104 in 105 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $965 · 2025 $2,104
Food & beverage: $2,104
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $390 |
| Axsome Therapeutics, Inc. | 19 | $343 |
| Aimmune Therapeutics, Inc. | 9 | $308 |
| AstraZeneca Pharmaceuticals LP | 10 | $213 |
| Phathom Pharmaceuticals, Inc. | 18 | $167 |
| Lilly USA, LLC | 11 | $145 |
| E.R. Squibb & Sons, L.L.C. | 4 | $93 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $81 |
| ABBVIE INC. | 4 | $77 |
| Exact Sciences Corporation | 3 | $60 |
Products named: Auvelity, ZENPEP, VOQUEZNA, Ozempic, MOUNJARO, AIRSUPRA, CAPLYTA, ELIQUIS.
Industry payments across WI — which companies pay providers there.
